Ward MA - Search Results

1

Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia.

Ward MA, Fang G, Richards KL, Walko CM, Earnshaw SR, Happe LE, Blalock SJ. Ward MA, et al. J Health Econ Outcomes Res. 2015 Apr 27;2(2):181-191. doi: 10.36469/9899. eCollection 2015. J Health Econ Outcomes Res. 2015. PMID: 37663584 Free PMC article.

2

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs.

Ward MA, Fang G, Richards KL, Walko CM, Earnshaw SR, Happe LE, Blalock SJ. Ward MA, et al. Curr Med Res Opin. 2015 Feb;31(2):289-97. doi: 10.1185/03007995.2014.991440. Epub 2014 Dec 10. Curr Med Res Opin. 2015. PMID: 25420131

3

Is response-guided therapy being applied in the clinical setting? The hepatitis C example.

Harris JB, Ward MA, Schwab P. Harris JB, et al. Among authors: ward ma. Am Health Drug Benefits. 2015 Feb;8(1):22-8. Am Health Drug Benefits. 2015. PMID: 25964830 Free PMC article.

4

Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: where do we go from here?

Hayes MS, Ward MA, Slabaugh SL, Xu Y. Hayes MS, et al. Among authors: ward ma. Am Health Drug Benefits. 2014 Aug;7(5):264-70. Am Health Drug Benefits. 2014. PMID: 25237422 Free PMC article.

5

Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan.

Xu Y, Viswanathan HN, Ward MA, Clay B, Adams JL, Stolshek BS, Kallich JD, Fine S, Saag KG. Xu Y, et al. Among authors: ward ma. J Eval Clin Pract. 2013 Feb;19(1):50-9. doi: 10.1111/j.1365-2753.2011.01766.x. Epub 2011 Sep 13. J Eval Clin Pract. 2013. PMID: 21914091

6

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.

Bergeson JG, Worley K, Louder A, Ward M, Graham J. Bergeson JG, et al. J Manag Care Pharm. 2013 Jun;19(5):374-84. doi: 10.18553/jmcp.2013.19.5.374. J Manag Care Pharm. 2013. PMID: 23697475 Free PMC article.

7

Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based Analysis.

Brown VT, Antol DD, Racsa PN, Ward MA, Naidoo J. Brown VT, et al. Among authors: ward ma. Cancer Invest. 2021 Nov;39(10):789-796. doi: 10.1080/07357907.2021.1913502. Epub 2021 Sep 27. Cancer Invest. 2021. PMID: 33829943

8

Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries.

Doshi JA, Jahnke J, Raman S, Puckett JT, Brown VT, Ward MA, Li P, Manz CR. Doshi JA, et al. Among authors: ward ma. J Manag Care Spec Pharm. 2021 Oct;27(10):1457-1468. doi: 10.18553/jmcp.2021.27.10.1457. J Manag Care Spec Pharm. 2021. PMID: 34595957 Free PMC article.

9

Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan.

Ward MA, Xu Y, Viswanathan HN, Stolshek BS, Clay B, Adams JL, Kallich JD, Fine S, Saag KG. Ward MA, et al. Osteoporos Int. 2013 Apr;24(4):1195-206. doi: 10.1007/s00198-012-2140-5. Epub 2012 Oct 26. Osteoporos Int. 2013. PMID: 23100119

10

Pharmacist-provided telephonic medication therapy management in an MAPD plan.

Ward MA, Xu Y. Ward MA, et al. Am J Manag Care. 2011 Oct 1;17(10):e399-409. Am J Manag Care. 2011. PMID: 21999720 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters